FTO and cancer: A variety of FTO-targeted inhibitors have been developed, including MO-I-500, meclofenamic acid (MA), FB23, R-2HG, and rhodopsin, which significantly inhibit the proliferation of cancer cells by inhibiting the enzymatic activity of FTO (108).